Stay updated with breaking news from Wolfe Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Honeycomb Asset Management LP purchased a new stake in Paramount Global (NASDAQ:PARA – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,000,000 shares of the company’s stock, valued at approximately $14,790,000. Paramount Global accounts for approximately 3.5% of Honeycomb Asset […]
ORCL earnings call for the period ending March 31, 2024.
Point72 Asset Management L.P. increased its position in shares of AT&T Inc. (NYSE:T – Free Report) by 120.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 9,086,854 shares of the technology company’s stock after buying an additional 4,970,954 shares during the period. Point72 Asset Management L.P.’s holdings in AT&T were worth $152,477,000 as of […]
Point72 Asset Management L.P. raised its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,756,122 shares of the biopharmaceutical company’s stock after acquiring an additional 1,413,722 shares during the […]
Point72 Asset Management L.P. bought a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,666,883 shares of the company’s stock, valued at approximately $112,356,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Headlands Technologies LLC acquired […]